Sarepta Therapeutics grants 8,040 RSUs to new hires, vesting over four years, following Nasdaq rules.

Sarepta Therapeutics, a company that develops treatments for rare diseases, granted 14 new November hires equity awards totaling 8,040 restricted stock units (RSUs). The awards, approved by the company's Compensation Committee, vest in equal parts over four years. This follows Nasdaq Listing Rule 5635(c)(4).

November 29, 2024
5 Articles